Clinical Trial Update: Trial Evaluating the Efficacy of Systemic Mesenchymal Stromal Cell (MSC) Injections for the Treatment of Severe and Chronic Radiotherapy-induced Abdomino-pelvic Complications (Pelvic Radiation Disease, PRD) Refractory to Standard Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating systemic mesenchymal stromal cell injections for severe radiotherapy-induced abdomino-pelvic complications (pelvic radiation disease) r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pelvic Radiation Disease
• Radiation-induced Hemorrhagic Cystitis

Drugs mentioned

• Mesenchymal stromal cells

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Pelvic Radiation Therapy, Radiation-induced Hemorrhagic Cystitis | Phase 2 | Status: UNKNOWN